Memantine Dosing for OCD Augmentation
Start memantine at 5mg daily for one week, then increase to 10mg daily for one week, followed by a target dose of 20mg daily for OCD augmentation. 1, 2
Dosing Protocol
Initial titration schedule:
- Week 1: 5mg once daily
- Week 2: 10mg once daily
- Week 3 onward: 20mg once daily (target dose) 2
This gradual titration minimizes side effects while achieving the therapeutic dose demonstrated in clinical trials. 2
Evidence Base and Positioning
Memantine is a third-line augmentation option for treatment-resistant OCD, recommended only after you have optimized SSRI dose and duration, tried switching to another SSRI or clomipramine, attempted antipsychotic augmentation (risperidone or aripiprazole), and considered N-acetylcysteine. 1
The evidence for memantine is mixed and controversial:
- One double-blind RCT showed 89% remission rates with memantine augmentation versus 32% with placebo when added to fluvoxamine at 20mg daily. 2
- However, a critical 2019 analysis found that all four RCTs supporting memantine came from the same geographical area and presented completer analyses rather than intention-to-treat data, significantly compromising validity. 3
- The meta-analysis showing very large benefits (81% response vs 19% placebo) cannot be considered sound due to these methodological concerns. 3
Despite these limitations, memantine has demonstrated efficacy in several trials and can be considered in clinical practice given its favorable safety profile. 1, 4
Critical Considerations for Your Patient
Drug interaction concerns:
- Memantine has no significant interactions with Vraylar (cariprazine), Concerta (methylphenidate), Zepbound (tirzepatide), or propranolol. 1
- Important caveat: One case series reported lamotrigine-induced OCD in bipolar patients, with symptoms developing 2-8 months after lamotrigine initiation. 5 Your patient on Lamictal 350mg may have lamotrigine-contributing to OCD symptoms, though this is rare and controversial.
Monitoring requirements:
- Memantine has minimal metabolic side effects compared to antipsychotic augmentation, requiring no routine laboratory monitoring. 6, 1
- Watch for dizziness, headache, and confusion during titration. 2
Alternative Strategies with Stronger Evidence
Before adding memantine, ensure you have:
- Confirmed adequate SSRI trial (maximum tolerated dose for 8-12 weeks with documented adherence) 7
- Added or optimized Cognitive Behavioral Therapy with Exposure and Response Prevention (ERP), which has larger effect sizes than any pharmacological augmentation. 7, 6
If memantine fails or is not tolerated:
- N-acetylcysteine has stronger evidence (3 out of 5 RCTs positive) with doses of 1200-2400mg daily. 7, 6
- Deep rTMS is FDA-approved for treatment-resistant OCD with moderate effect size (0.65) and 3-fold increased response versus sham. 7, 6
Treatment Duration
Maintain memantine for at least 8 weeks to assess response, and if effective, continue for 12-24 months after achieving remission due to high OCD relapse rates. 7